南洋股份(002212.SZ)已簽訂第二批合同 金額2.08億元
格隆匯11月25日丨南洋股份(002212.SZ)公佈,公司的全資子公司廣州南洋電纜有限公司(“廣州南洋”)為以下招標項目的中標單位。
截至2019年11月25日,上述標包中廣州南洋已簽訂並收到原件的合同金額總合計達到約4.15億元(其中第一批2.07億元的合同已於2019年8月26日披露),此次公告為上述標包已簽訂並收到原件的第二批合同,該批合同金額約2.08億元。
該批合同的簽訂總金額佔公司2018年度經審計營業總收入的3.30%,合同的履行預計將對公司2019年的經營業績產生一定的積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.